{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:34:14Z","timestamp":1790087654059,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Mutations in\n                      <jats:italic>ABHD12<\/jats:italic>\n                      (OMIM: 613,599) are associated with polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC) syndrome (OMIM: 612674), which is a rare autosomal recessive neurodegenerative disease. PHARC syndrome is easily misdiagnosed as other neurologic disorders, such as retinitis pigmentosa, Charcot-Marie-Tooth disease, and Refsum disease, due to phenotype variability and slow progression. This paper presents a novel mutation in\n                      <jats:italic>ABHD12<\/jats:italic>\n                      in two affected siblings with PHARC syndrome phenotypes. In addition, we summarize genotype-phenotype information of the previously reported patients with\n                      <jats:italic>ABHD12<\/jats:italic>\n                      mutation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following a thorough medical evaluation, whole-exome sequencing was done on the proband to look for potential genetic causes. This was followed by confirmation of identified variant in the proband and segregation analysis in the family by Sanger sequencing. The variants were interpreted based on the American College of Medical Genetics and Genomics (ACMG) guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A novel pathogenic homozygous frameshift variant, NM_001042472.3:c.601dup, p.(Val201GlyfsTer4), was identified in exon 6 of\n                      <jats:italic>ABHD12<\/jats:italic>\n                      (ACMG criteria: PVS1 and PM2, PM1, PM4, PP3, and PP4). Through Sanger sequencing, we showed that this variant is co-segregated with the disease in the family. Further medical evaluations confirmed the compatibility of the patients\u2019 phenotype with PHARC syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings expand the spectrum of mutations in the\n                      <jats:italic>ABHD12<\/jats:italic>\n                      and emphasize the significance of multidisciplinary diagnostic collaboration among clinicians and geneticists to solve the differential diagnosis of related disorders. Moreover, a summary based on mutations found so far in the\n                      <jats:italic>ABHD12<\/jats:italic>\n                      gene did not suggest a clear genotype-phenotype correlation for PHARC syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-023-01682-w","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T05:02:05Z","timestamp":1696568525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Genetic insights into PHARC syndrome: identification of a novel frameshift mutation in ABHD12"],"prefix":"10.1186","volume":"16","author":[{"given":"Ahmad","family":"Daneshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Garshasbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil Ghasemi","family":"Falavarjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Vafaee-Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Almadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammadSina","family":"Zabihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Ghalavand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Falah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"issue":"1","key":"1682_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archopht.124.1.95","volume":"124","author":"BL Lam","year":"2006","unstructured":"Lam BL, Lee DJ, G\u00f3mez-Mar\u00edn O, Zheng DD, Caban AJ. Concurrent visual and hearing impairment and risk of mortality: the National Health interview survey. Archives of Ophthalmology (Chicago Ill: 1960). 2006;124(1):95\u2013101.","journal-title":"Archives of Ophthalmology (Chicago Ill: 1960)"},{"issue":"11","key":"1682_CR2","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/humu.23630","volume":"39","author":"AM Oza","year":"2018","unstructured":"Oza AM, DiStefano MT, Hemphill SE, Cushman BJ, Grant AR, Siegert RK, et al. Expert specification of the ACMG\/AMP variant interpretation guidelines for genetic hearing loss. Hum Mutat. 2018;39(11):1593\u2013613.","journal-title":"Hum Mutat"},{"key":"1682_CR3","doi-asserted-by":"crossref","unstructured":"Chia E-M, Mitchell P, Rochtchina E, Foran S, Golding M, Wang JJJA. Association between vision and hearing impairments and their combined effects on quality of life. 2006;124(10):1465\u201370.","DOI":"10.1001\/archopht.124.10.1465"},{"key":"1682_CR4","doi-asserted-by":"crossref","unstructured":"Liljas AE, Wannamethee SG, Whincup PH, Papacosta O, Walters K, Iliffe S et al. Socio-demographic characteristics, lifestyle factors and burden of morbidity associated with self-reported hearing and vision impairments in older british community-dwelling men: a cross-sectional study. 2016;38(2):e21\u2013e8.","DOI":"10.1093\/pubmed\/fdv095"},{"issue":"3","key":"1682_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1475-1313.2012.00897.x","volume":"32","author":"W Wittich","year":"2012","unstructured":"Wittich W, Watanabe DH, Gagn\u00e9 JP. Sensory and demographic characteristics of deafblindness rehabilitation clients in Montr\u00e9al. Can Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists). 2012;32(3):242\u201351.","journal-title":"Can Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists)"},{"issue":"8","key":"1682_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/GIM.0b013e3181e5afb8","volume":"12","author":"WJ Kimberling","year":"2010","unstructured":"Kimberling WJ, Hildebrand MS, Shearer AE, Jensen ML, Halder JA, Trzupek K, et al. Frequency of Usher syndrome in two pediatric populations: implications for genetic screening of deaf and hard of hearing children. Genet Medicine: Official J Am Coll Med Genet. 2010;12(8):512\u20136.","journal-title":"Genet Medicine: Official J Am Coll Med Genet"},{"issue":"3","key":"1682_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ajhg.2010.08.002","volume":"87","author":"T Fiskerstrand","year":"2010","unstructured":"Fiskerstrand T, H\u2019Mida-Ben Brahim D, Johansson S, M\u2019Zahem A, Haukanes BI, Drouot N, et al. Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism. Am J Hum Genet. 2010;87(3):410\u20137.","journal-title":"Am J Hum Genet"},{"key":"1682_CR8","doi-asserted-by":"crossref","unstructured":"Nguyen XT, Almushattat H, Strubbe I, Georgiou M, Li CHZ, van Schooneveld MJ et al. The phenotypic spectrum of patients with PHARC Syndrome due to Variants in ABHD12: an Ophthalmic Perspective. Genes. 2021;12(9).","DOI":"10.3390\/genes12091404"},{"issue":"6","key":"1682_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/mdc3.13266","volume":"8","author":"PA Dias Bastos","year":"2021","unstructured":"Dias Bastos PA, Mendon\u00e7a M, Lampreia T, Magri\u00e7o M, Oliveira J, Barbosa R. PHARC Syndrome, a Rare Genetic disorder-case report. Mov Disorders Clin Pract. 2021;8(6):977\u20139.","journal-title":"Mov Disorders Clin Pract"},{"issue":"3","key":"1682_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, B\u00e1tkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389\u2013462.","journal-title":"Pharmacol Rev"},{"issue":"12","key":"1682_CR11","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/humu.22437","volume":"34","author":"DH Chen","year":"2013","unstructured":"Chen DH, Naydenov A, Blankman JL, Mefford HC, Davis M, Sul Y, et al. Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects. Hum Mutat. 2013;34(12):1672\u20138.","journal-title":"Hum Mutat"},{"issue":"2","key":"1682_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jns.12216","volume":"22","author":"J Lerat","year":"2017","unstructured":"Lerat J, Cintas P, Beauvais-Dzugan H, Magdelaine C, Sturtz F, Lia AS. A complex homozygous mutation in ABHD12 responsible for PHARC syndrome discovered with NGS and review of the literature. J Peripheral Nerv System: JPNS. 2017;22(2):77\u201384.","journal-title":"J Peripheral Nerv System: JPNS"},{"key":"1682_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2147\/CIA.S123278","volume":"12","author":"M Falah","year":"2017","unstructured":"Falah M, Farhadi M, Kamrava SK, Mahmoudian S, Daneshi A, Balali M, et al. Association of genetic variations in the mitochondrial DNA control region with presbycusis. Clin Interv Aging. 2017;12:459\u201365.","journal-title":"Clin Interv Aging"},{"issue":"1","key":"1682_CR14","first-page":"49","volume":"15","author":"M Falah","year":"2012","unstructured":"Falah M, Houshmand M, Mahmoudian S, Emamdjomeh H, Ghavami Y, Farhadi M. The anticipation and inheritance pattern of c.487A > G mutation in the GJB2 gene. Arch Iran Med. 2012;15(1):49\u201351.","journal-title":"Arch Iran Med"},{"issue":"1","key":"1682_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12920-022-01287-9","volume":"15","author":"S Rayat","year":"2022","unstructured":"Rayat S, Farhadi M, Emamdjomeh H, Morovvati S, Falah M. Analysis of TMIE gene mutations including the first large deletion of exon 1 with autosomal recessive non-syndromic deafness. BMC Med Genom. 2022;15(1):133.","journal-title":"BMC Med Genom"},{"key":"1682_CR16","doi-asserted-by":"crossref","unstructured":"Vafaee-Shahi M, Farhadi M, Razmara E, Morovvati S, Ghasemi S, Abedini SS et al. Novel phenotype and genotype spectrum of NARS2 and literature review of previous mutations. Ir J Med Sci. 2021.","DOI":"10.1007\/s11845-021-02736-7"},{"issue":"1","key":"1682_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/nar\/28.1.352","volume":"28","author":"EM Smigielski","year":"2000","unstructured":"Smigielski EM, Sirotkin K, Ward M, Sherry ST. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 2000;28(1):352\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"7809","key":"1682_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","journal-title":"Nature"},{"issue":"11","key":"1682_CR19","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/humu.23880","volume":"40","author":"Z Fattahi","year":"2019","unstructured":"Fattahi Z, Beheshtian M, Mohseni M, Poustchi H, Sellars E, Nezhadi SH, et al. Iranome: a catalog of genomic variations in the iranian population. Hum Mutat. 2019;40(11):1968\u201384.","journal-title":"Hum Mutat"},{"key":"1682_CR20","doi-asserted-by":"crossref","unstructured":"Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40(Web Server issue):W452\u20137.","DOI":"10.1093\/nar\/gks539"},{"issue":"4","key":"1682_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139.","journal-title":"Nat Methods"},{"issue":"4","key":"1682_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361\u20132.","journal-title":"Nat Methods"},{"issue":"16","key":"1682_CR23","first-page":"2745","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinf (Oxford England). 2015;31(16):2745\u20137.","journal-title":"Bioinf (Oxford England)"},{"issue":"D1","key":"1682_CR24","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886\u2013d94.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1682_CR25","doi-asserted-by":"publisher","first-page":"D835","DOI":"10.1093\/nar\/gkz972","volume":"48","author":"MJ Landrum","year":"2020","unstructured":"Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B, Hart J, et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 2020;48(D1):D835\u2013d44.","journal-title":"Nucleic Acids Res"},{"key":"1682_CR26","doi-asserted-by":"crossref","unstructured":"Stenson PD, Ball EV, Mort M, Phillips AD, Shaw K, Cooper DN. The human gene mutation database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution. Curr Protocols Bioinf. 2012;Chap. 1:Unit1.13.","DOI":"10.1002\/0471250953.bi0113s39"},{"issue":"D1","key":"1682_CR27","doi-asserted-by":"publisher","first-page":"D865","DOI":"10.1093\/nar\/gkw1039","volume":"45","author":"S K\u00f6hler","year":"2017","unstructured":"K\u00f6hler S, Vasilevsky NA, Engelstad M, Foster E, McMurry J, Aym\u00e9 S, et al. The human phenotype ontology in 2017. Nucleic Acids Res. 2017;45(D1):D865\u2013d76.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1682_CR28","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ajhg.2018.08.006","volume":"103","author":"H Azaiez","year":"2018","unstructured":"Azaiez H, Booth KT, Ephraim SS, Crone B, Black-Ziegelbein EA, Marini RJ, et al. Genomic Landscape and Mutational Signatures of Deafness-Associated genes. Am J Hum Genet. 2018;103(4):484\u201397.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"1682_CR29","first-page":"1937","volume":"34","author":"T K\u00f5ressaar","year":"2018","unstructured":"K\u00f5ressaar T, Lepamets M, Kaplinski L, Raime K, Andreson R, Remm M. Primer3_masker: integrating masking of template sequence with primer design software. Bioinf (Oxford England). 2018;34(11):1937\u20138.","journal-title":"Bioinf (Oxford England)"},{"issue":"D1","key":"1682_CR30","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"UniProt","year":"2023","unstructured":"UniProt. The Universal protein knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523\u2013d31.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1682_CR31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.23892","volume":"40","author":"L Wiel","year":"2019","unstructured":"Wiel L, Baakman C, Gilissen D, Veltman JA, Vriend G, Gilissen C, MetaDome. Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Hum Mutat. 2019;40(8):1030\u20138.","journal-title":"Hum Mutat"},{"issue":"3","key":"1682_CR32","first-page":"213","volume":"14","author":"M Falah","year":"2011","unstructured":"Falah M, Houshmand M, Akbaroghli S, Mahmodian S, Ghavami Y, Farhadi M. Profile of iranian GJB2 mutations in young population with novel mutation. J Iran J Basic Med Sci. 2011;14(3):213\u20138.","journal-title":"J Iran J Basic Med Sci"},{"issue":"1","key":"1682_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15513815.2019.1627625","volume":"39","author":"M Falah","year":"2020","unstructured":"Falah M, Houshmand M, Balali M, Asghari A, Bagher Z, Alizadeh R, et al. Role of GJB2 and GJB6 in iranian nonsyndromic hearing impairment: from Molecular Analysis to Literature Reviews. Fetal Pediatr Pathol. 2020;39(1):1\u201312.","journal-title":"Fetal Pediatr Pathol"},{"issue":"6","key":"1682_CR34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1080\/13816810.2021.1946704","volume":"42","author":"AD Igelman","year":"2021","unstructured":"Igelman AD, Ku C, da Palma MM, Georgiou M, Schiff ER, Lam BL, et al. Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome. Ophthalmic Genet. 2021;42(6):664\u201373.","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"1682_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jns.12367","volume":"25","author":"A Thimm","year":"2020","unstructured":"Thimm A, Rahal A, Schoen U, Abicht A, Klebe S, Kleinschnitz C, et al. Genotype-phenotype correlation in a novel ABHD12 mutation underlying PHARC syndrome. J Peripheral Nerv System: JPNS. 2020;25(2):112\u20136.","journal-title":"J Peripheral Nerv System: JPNS"},{"key":"1682_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.gene.2019.04.008","volume":"704","author":"T Li","year":"2019","unstructured":"Li T, Feng Y, Liu Y, He C, Liu J, Chen H, et al. A novel ABHD12 nonsense variant in Usher syndrome type 3 family with genotype-phenotype spectrum review. Gene. 2019;704:113\u201320.","journal-title":"Gene"},{"key":"1682_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jns.2018.02.021","volume":"387","author":"M Frasquet","year":"2018","unstructured":"Frasquet M, Lupo V, Chumillas MJ, V\u00e1zquez-Costa JF, Espin\u00f3s C, Sevilla T. Phenotypical features of two patients diagnosed with PHARC syndrome and carriers of a new homozygous mutation in the ABHD12 gene. J Neurol Sci. 2018;387:134\u20138.","journal-title":"J Neurol Sci"},{"key":"1682_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nbd.2016.11.008","volume":"98","author":"A Tingaud-Sequeira","year":"2017","unstructured":"Tingaud-Sequeira A, Rald\u00faa D, Lavie J, Mathieu G, Bordier M, Knoll-Gellida A, et al. Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC. Neurobiol Dis. 2017;98:36\u201351.","journal-title":"Neurobiol Dis"},{"key":"1682_CR39","doi-asserted-by":"crossref","unstructured":"Yoshimura H, Hashimoto T, Murata T, Fukushima K, Sugaya A, Nishio SY et al. Novel ABHD12 mutations in PHARC patients: the differential diagnosis of deaf-blindness. The Annals of otology, rhinology, and laryngology. 2015;124 Suppl 1:77s-83s.","DOI":"10.1177\/0003489415574513"},{"issue":"8","key":"1682_CR40","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.ophtha.2014.02.008","volume":"121","author":"KM Nishiguchi","year":"2014","unstructured":"Nishiguchi KM, Avila-Fernandez A, van Huet RA, Corton M, P\u00e9rez-Carro R, Mart\u00edn-Garrido E, et al. Exome sequencing extends the phenotypic spectrum for ABHD12 mutations: from syndromic to nonsyndromic retinal degeneration. Ophthalmology. 2014;121(8):1620\u20137.","journal-title":"Ophthalmology"},{"key":"1682_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1750-1172-7-59","volume":"7","author":"T Eisenberger","year":"2012","unstructured":"Eisenberger T, Slim R, Mansour A, Nauck M, N\u00fcrnberg G, N\u00fcrnberg P, et al. Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3. Orphanet J Rare Dis. 2012;7:59.","journal-title":"Orphanet J Rare Dis"},{"key":"1682_CR42","doi-asserted-by":"crossref","unstructured":"Corriols-Noval P, L\u00f3pez Sim\u00f3n EC, Cadi\u00f1anos J, Di\u00f1eiro M, Cap\u00edn R, Gonz\u00e1lez Aguado R et al. Clinical Impact of Genetic Diagnosis of Sensorineural Hearing Loss in Adults. Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2022;43(10):1125-36.","DOI":"10.1097\/MAO.0000000000003706"},{"key":"1682_CR43","first-page":"1260419","volume-title":"Proteomics. Tissue-based map of the human proteome","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Volume 347. New York, NY: Science; 2015. p. 1260419. 6220."},{"issue":"7","key":"1682_CR44","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.4103\/ijo.IJO_2916_20","volume":"69","author":"S Chatterjee","year":"2021","unstructured":"Chatterjee S, Agrawal D, Agrawal D, Parchand SM, Sahu A. Cataract surgery in retinitis pigmentosa. Indian J Ophthalmol. 2021;69(7):1753\u20137.","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"1682_CR45","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1073\/pnas.1217121110","volume":"110","author":"JL Blankman","year":"2013","unstructured":"Blankman JL, Long JZ, Trauger SA, Siuzdak G, Cravatt BF. ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc Natl Acad Sci USA. 2013;110(4):1500\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1682_CR46","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41589-018-0155-8","volume":"14","author":"D Ogasawara","year":"2018","unstructured":"Ogasawara D, Ichu TA, Vartabedian VF, Benthuysen J, Jing H, Reed A, et al. Selective blockade of the lyso-PS lipase ABHD12 stimulates immune responses in vivo. Nat Chem Biol. 2018;14(12):1099\u2013108.","journal-title":"Nat Chem Biol"},{"issue":"10","key":"1682_CR47","doi-asserted-by":"publisher","first-page":"7442","DOI":"10.1111\/ejn.15516","volume":"54","author":"S Singh","year":"2021","unstructured":"Singh S, Kamat SS. The loss of enzymatic activity of the PHARC-associated lipase ABHD12 results in increased phagocytosis that causes neuroinflammation. Eur J Neurosci. 2021;54(10):7442\u201357.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"1682_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","volume":"204","author":"JR Savinainen","year":"2012","unstructured":"Savinainen JR, Saario SM, Laitinen JT. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiologica (Oxford England). 2012;204(2):267\u201376.","journal-title":"Acta Physiologica (Oxford England)"},{"issue":"11","key":"1682_CR49","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1194\/jlr.M030411","volume":"53","author":"D Navia-Paldanius","year":"2012","unstructured":"Navia-Paldanius D, Savinainen JR, Laitinen JT. Biochemical and pharmacological characterization of human \u03b1\/\u03b2-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12). J Lipid Res. 2012;53(11):2413\u201324.","journal-title":"J Lipid Res"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01682-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01682-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01682-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T01:25:41Z","timestamp":1700357141000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01682-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1682"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01682-w","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"assertion":[{"value":"8 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance to the guidelines of the Declaration of Helsinki, and approved by the ethics committee of Iran University of Medical Sciences (Tehran, Iran). (Approval number: IR.IUMS.REC.1400.862). Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical details and clinical images was obtained from the legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}